Welcome Visitor Wednesday, September 18, 2019

Articles related to Bob Galloway


Nashville pioneer Pathfinder Technologies moving to sell to Analogic
Nashville pioneer Pathfinder Technologies moving to sell to Analogic

After a decade widening Nashville's lifesciences entrepreneurship, a strategic move.

Read More
Google exec who launched Earth, Moon & Mars<br> returns to Vanderbilt School of Engineering
Google exec who launched Earth, Moon & Mars
returns to Vanderbilt School of Engineering
Chikai Ohazama, a Vanderbilt Engineering alum, drops-in later this week to share his Google adventure with students
Read More
VU School of Engineering alumni spawn businesses
VU School of Engineering alumni spawn businesses
It may be only the tip of the Engineering iceberg at Vanderbilt, but here's a sample of the fruits of education and research
Read More
Pathfinder's Stefansic comments on Nashville leverage, challenges
Pathfinder's Stefansic comments on Nashville leverage, challenges
Quiet figure behind the scenes of a Vanderbilt-spawned startup steps forward with observations and appreciation
Read More
Vanderbilt venture developer notes 'disconnect' with Venture Capital
Vanderbilt venture developer notes 'disconnect' with Venture Capital
Christopher Rand's presentation underscores gaps in the capital continuum, but suggests a target-rich environment for seed-stage investors
Read More
VUMC's Jacobson will never buy lunch in this town, again
VUMC's Jacobson will never buy lunch in this town, again

Legendary physician-entrepreneur-scientist's departure from VU leadership ranks leaves venture community asking whether he'll remain involved

Read More
VC CEO steps aside for new man at Pathfinder Therapeutics
VC CEO steps aside for new man at Pathfinder Therapeutics
UPDATED 12:44 p.m.Nationwide search lands med-devices veteran for persistent Vanderbilt spin-out
Read More
UPDATE:  Pathfinder Therapeutics is back on the money trail
UPDATE: Pathfinder Therapeutics is back on the money trail
Making scientific discoveries that can survive the punishing path toward the market is hard enough. Now that the FDA has approved marketing that could save liver-cancer patients' lives, Pathfinder Therapeutics hopes local investors and the State of Tennessee can lend a hand. But, they're not holding their breath.
Read More

Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: